CAI

$32.852.34%0.75

Nachbörslich: 33.01+0.16 +0.49%

Caris Life Sciences Inc (CAI)

Date: O: H: L: C: Vol:

Schlusskurs vom Vortag:

$32.10

Offen:

$32.27

24-Stunden-Volumen:

2,628,496

Relatives Volumen:

0.88

Marktkapitalisierung:

$9.28B

Einnahmen:

$907.29M

Nettoeinkommen (Verlust:

$33.98M

KGV:

EPS:

-$1.47

Netto-Cashflow:

$115.75M

1W Leistung:

-2.44%

1M Leistung:

+16.08%

6M Leistung:

+77.86%

1Y Leistung:

+9.72%

1-Tages-Spanne:

$32.14$34.00

1-Wochen-Bereich:

$32.03$36.50

52-Wochen-Spanne:

$14.19$36.50

Caris Life Sciences Inc Aktie (CAI) Unternehmensprofil

Firmenname

Caris Life Sciences Inc

Sektor

Healthcare

Branche

Biotechnology

Telefon

(866) 771-8946

Adresse

750 W JOHN CARPENTER FREEWAY, IRVING, USA

Mitarbeiter

1,846

Nächster Verdiensttermin

2026-11-04

Neueste SEC-Einreichungen

SEC

CAI-Diskussionen auf X

Marktkapitalisierung

Umsatz

Nettogewinn

Free Cashflow

ENV

Caris Life Sciences Inc Aktie (CAI) Hochstufungen & Herabstufungen

Datum	Aktion	Analytiker	Ratingänderung
2026-09-09	Eingeleitet	UBS	Neutral
2026-06-02	Resumed	Wolfe Research	Peer Perform
2026-04-13	Eingeleitet	Jefferies	Buy
2026-04-10	Eingeleitet	Piper Sandler	Neutral
2026-04-01	Eingeleitet	Goldman	Buy
2026-02-17	Eingeleitet	Robert W. Baird	Outperform
2025-12-02	Eingeleitet	Canaccord Genuity	Hold
2025-07-14	Eingeleitet	BTIG Research	Buy
2025-07-14	Eingeleitet	BofA Securities	Buy
2025-07-14	Eingeleitet	Citigroup	Buy
2025-07-14	Eingeleitet	Evercore ISI	Outperform
2025-07-14	Eingeleitet	Guggenheim	Buy
2025-07-14	Eingeleitet	JP Morgan	Overweight
2025-07-14	Eingeleitet	TD Cowen	Buy
2025-07-14	Eingeleitet	Wolfe Research	Outperform
2021-06-30	Herabstufung	Keefe Bruyette	Outperform → Mkt Perform
2021-06-21	Herabstufung	William Blair	Outperform → Mkt Perform
2021-06-09	Resumed	B. Riley Securities	Buy
2020-12-09	Eingeleitet	B. Riley Securities	Buy
2020-10-19	Hochstufung	Keefe Bruyette	Mkt Perform → Outperform
2020-06-15	Herabstufung	Keefe Bruyette	Outperform → Mkt Perform
2020-05-07	Hochstufung	Keefe Bruyette	Mkt Perform → Outperform
2019-11-05	Herabstufung	Cowen	Outperform → Market Perform
2019-08-08	Bestätigt	Cowen	Outperform
2019-02-21	Herabstufung	Keefe Bruyette	Outperform → Mkt Perform
2018-10-31	Bestätigt	Cowen	Outperform
2018-09-28	Herabstufung	Wells Fargo	Outperform → Market Perform
2018-09-07	Hochstufung	Keefe Bruyette	Mkt Perform → Outperform
2018-04-24	Eingeleitet	Compass Point	Buy
2018-02-15	Bestätigt	Cowen	Outperform
2018-02-14	Hochstufung	Wells Fargo	Market Perform → Outperform
2017-10-23	Hochstufung	Cowen	Market Perform → Outperform
2017-07-27	Bestätigt	Cowen	Market Perform
2017-04-21	Bestätigt	Cowen	Market Perform
2016-05-04	Bestätigt	Cowen	Market Perform
2016-02-17	Bestätigt	Cowen	Market Perform
2016-01-15	Resumed	Keefe Bruyette	Mkt Perform

Finanzdaten der Caris Life Sciences Inc-Aktie (CAI)

Zeitraum	Trend	FY 2025
Enddatum des Zeitraums		2025-12-31
Revenue USD (M)		812.03
Research and development USD (M)		101.58
Operating expenses USD (M)		766.92
Operating income USD (M)		45.11
Income before tax USD (M)		-68.09
Income tax expense USD (M)		0.00
Net income USD (M)		-68.09
Basic EPS USD/shares		-3.22
Diluted EPS USD/shares		-3.22
Basic weighted shares shares (M)		167.21
Diluted weighted shares shares (M)		167.21

Caris Life Sciences Inc-Aktie (CAI) Insiderhandel

Denton John RusselSep 22 '26
See Remarks
Transaktion
Sale
Kosten
$31.82
#Aktien
7,500
Wert ($)
238,626
#Aktien Gesamt
174,855
JOHN RUSSEL DENTONSep 22 '26
Officer
Transaktion
Proposed Sale
Kosten
$31.82
#Aktien
7,500
Wert ($)
238,626
#Aktien Gesamt
0
BRIAN J BRILLESep 17 '26
Officer
Transaktion
Proposed Sale
Kosten
$30.33
#Aktien
400,000
Wert ($)
12,132,080
#Aktien Gesamt
0
Brille Brian JSep 17 '26
See Remarks
Transaktion
Option Exercise
Kosten
$2.44
#Aktien
400,000
Wert ($)
976,000
#Aktien Gesamt
630,303
Brille Brian JSep 17 '26
See Remarks
Transaktion
Sale
Kosten
$30.33
#Aktien
400,000
Wert ($)
12,132,080
#Aktien Gesamt
230,303
Spetzler David BaxleySep 04 '26
President
Transaktion
Sale
Kosten
$24.76
#Aktien
119,212
Wert ($)
2,951,117
#Aktien Gesamt
1,182,871
Spetzler David BaxleySep 04 '26
President
Transaktion
Option Exercise
Kosten
$2.44
#Aktien
250,000
Wert ($)
610,000
#Aktien Gesamt
1,302,083
DAVID SPETZLERSep 04 '26
Officer
Transaktion
Proposed Sale
Kosten
$24.76
#Aktien
119,212
Wert ($)
2,951,117
#Aktien Gesamt
0
Spetzler David BaxleySep 03 '26
President
Transaktion
Sale
Kosten
$24.86
#Aktien
478,000
Wert ($)
11,882,990
#Aktien Gesamt
1,052,083
DAVID SPETZLERSep 03 '26
Officer
Transaktion
Proposed Sale
Kosten
$24.86
#Aktien
478,000
Wert ($)
11,882,984
#Aktien Gesamt
0

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
Denton John Russel	See Remarks	Sep 22 '26	Sale	$31.82	7,500	238,626	174,855
JOHN RUSSEL DENTON	Officer	Sep 22 '26	Proposed Sale	$31.82	7,500	238,626	0
BRIAN J BRILLE	Officer	Sep 17 '26	Proposed Sale	$30.33	400,000	12,132,080	0
Brille Brian J	See Remarks	Sep 17 '26	Option Exercise	$2.44	400,000	976,000	630,303
Brille Brian J	See Remarks	Sep 17 '26	Sale	$30.33	400,000	12,132,080	230,303
Spetzler David Baxley	President	Sep 04 '26	Sale	$24.76	119,212	2,951,117	1,182,871
Spetzler David Baxley	President	Sep 04 '26	Option Exercise	$2.44	250,000	610,000	1,302,083
DAVID SPETZLER	Officer	Sep 04 '26	Proposed Sale	$24.76	119,212	2,951,117	0
Spetzler David Baxley	President	Sep 03 '26	Sale	$24.86	478,000	11,882,990	1,052,083
DAVID SPETZLER	Officer	Sep 03 '26	Proposed Sale	$24.86	478,000	11,882,984	0

Caris Life Sciences Inc Aktie (CAI) Neueste Nachrichten

Oct 28, 2026

Analysts Estimate Caris Life Sciences,?Inc. (CAI) to Report a Decline in Earnings: What to Look Out for - Zacks Investment Research

Oct 28, 2026

Jun 17, 2025

Caris Life Sciences (NasdaqGS:CAI) Stock Forecast & Analyst Predictions - Simply Wall Street

Jun 17, 2025

Sep 24, 2026

Form 4 Caris Life Sciences Inc For: 24 September By Investing.com - Investing.com Nigeria

Sep 24, 2026

Form 4 Caris Life Sciences Inc For: 24 September By Investing.com - Investing.com Canada

Sep 24, 2026

Caris Life Sciences SVP Denton sells $238,626 in shares By Investing.com - Investing.com Nigeria

Sep 24, 2026

Caris Life Sciences SVP Denton sells $238,626 in shares - Investing.com

Sep 24, 2026

Form 4 Caris Life Sciences Inc For: 24 September By Investing.com - Investing.com South Africa

Sep 24, 2026

Form 4 Caris Life Sciences Inc For: 24 September By Investing.com - Investing.com India

Sep 24, 2026

Form 4 Caris Life Sciences Inc For: 24 September By Investing.com - Investing.com UK

Sep 24, 2026

Sep 22, 2026

Insider at Caris Life Sciences (CAI) lines up stock sale - Stock Titan

Sep 22, 2026

Sep 18, 2026

Caris Life Sciences(CAI.US) Officer Sells US$12.13 Million in Common Stock - Moomoo

Sep 18, 2026

Caris Life Sciences vice chairman Brille sells $12.1 million shares By Investing.com - Investing.com UK

Sep 18, 2026

Sep 17, 2026

Caris Life Sciences (CAI) director plans 400,000-share sale - Stock Titan

Sep 17, 2026

Caris Life Sciences vice chairman Brille sells $12.1 million shares - Investing.com

Sep 17, 2026

Sep 14, 2026

New investor pitch from Caris Life Sciences (CAI) set for Morgan Stanley healthcare event - Stock Titan

Sep 14, 2026

Sep 12, 2026

UBS Group Upgrades Caris Life Sciences (NASDAQ:CAI) to "Hold" - MarketBeat

Sep 12, 2026

Amundi Buys 1,197,392 Shares of Caris Life Sciences, Inc. $CAI - MarketBeat

Sep 12, 2026

Sep 11, 2026

Squarepoint Ops LLC Acquires Shares of 380,927 Caris Life Sciences, Inc. $CAI - MarketBeat

Sep 11, 2026

Menlo Advisors LLC Acquires Shares of 300,518 Caris Life Sciences, Inc. $CAI - MarketBeat

Sep 11, 2026

Sep 09, 2026

UBS Initiates Coverage on Caris Life Sciences With Neutral Rating, $28 Price Target - marketscreener.com

Sep 09, 2026

Sep 08, 2026

Caris Life Sciences launches national campaign with Kevin Costner to promote early cancer detection test Caris Detect. - Pluang

Sep 08, 2026

Caris Life Sciences Launches New National Commercial Featuring Kevin Costner to Raise Awareness of Early Cancer Detection and Caris Detect - PR Newswire

Sep 08, 2026

Sep 06, 2026

Could Caris Life Sciences (CAI) Be 7% Undervalued After Its Lung Cancer Research Update? - Yahoo Finance

Sep 06, 2026

47,595 Shares in Caris Life Sciences, Inc. $CAI Acquired by The Manufacturers Life Insurance Company - MarketBeat

Sep 06, 2026

Sep 05, 2026

Caris Life Sciences (CAI) Will Present Seven Studies At A Global Lung Conference - Yahoo Finance

Sep 05, 2026

Bank of New York Mellon Corp Takes Position in Caris Life Sciences, Inc. $CAI - MarketBeat

Sep 05, 2026

Sep 04, 2026

David Baxley Spetzler Sells 478,000 Shares of Caris Life Sciences (NASDAQ:CAI) Stock - MarketBeat

Sep 04, 2026

Insider Selling: Caris Life Sciences (NASDAQ:CAI) President Sells 119,212 Shares of Stock - MarketBeat

Sep 04, 2026

President Spetzler sells $14.8m in Caris Life Sciences stock By Investing.com - Investing.com Nigeria

Sep 04, 2026

President Spetzler sells $14.8m in Caris Life Sciences stock By Investing.com - Investing.com South Africa

Sep 04, 2026

President Spetzler sells $14.8m in Caris Life Sciences stock By Investing.com - Investing.com Australia

Sep 04, 2026

President Spetzler sells $14.8m in Caris Life Sciences stock - Investing.com India

Sep 04, 2026

President Spetzler sells $14.8m in Caris Life Sciences stock - investing.com

Sep 04, 2026

President Spetzler sells $14.8m in Caris Life Sciences stock - Investing.com

Sep 04, 2026

After an $11.9M stock sale, Caris Life Sciences (NYSE: CAI) holder plans another - Stock Titan

Sep 04, 2026

President Spetzler sells $14.8m in Caris Life Sciences stock By Investing.com - Investing.com Canada

Sep 04, 2026

Sep 03, 2026

Insider at Caris Life Sciences (CAI) lines up 2026 stock sale tied to expiring options - Stock Titan

Sep 03, 2026

Braidwell LP Purchases 246,585 Shares of Caris Life Sciences, Inc. $CAI - MarketBeat

Sep 03, 2026

Sep 02, 2026

Caris Life Sciences to Present New Research Advancing Precision Oncology at the IASLC 2026 World Conference on Lung Cancer - Morningstar

Sep 02, 2026

Caris Life Sciences to Present New Research Advancing Precision Oncology at the IASLC 2026 World Conference on Lung Cancer - PR Newswire

Sep 02, 2026

One lung tumor pattern was linked to shorter survival and fewer immune cells. Caris studied 39,124 samples. - Stock Titan

Sep 02, 2026

Sep 01, 2026

Moore Capital Management LP Makes New Investment in Caris Life Sciences, Inc. $CAI - MarketBeat

Sep 01, 2026

Deutsche Bank AG Purchases New Position in Caris Life Sciences, Inc. $CAI - MarketBeat

Sep 01, 2026

Aug 30, 2026

BlackRock Inc. Acquires New Stake in Caris Life Sciences, Inc. $CAI - MarketBeat

Aug 30, 2026

Aug 29, 2026

Caris Life Sciences, Inc. (NASDAQ:CAI) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Aug 29, 2026

Canada Pension Plan Investment Board Purchases Shares of 1,374,952 Caris Life Sciences, Inc. $CAI - MarketBeat

Aug 29, 2026

Aug 28, 2026

Caris Life Sciences Publishes npj Precision Oncology Study Showing AI-Guided Therapy Selection is Predictive of Longer Survival in Patients with Pancreatic Cancer - sahmcapital.com

Aug 28, 2026

Aug 27, 2026

Caris Life Sciences Publishes npj Precision Oncology Study Showing AI-Guided Therapy Selection is Predictive of Longer Survival in Patients with Pancreatic Cancer - PR Newswire

Aug 27, 2026

PointState Capital LP Makes New Investment in Caris Life Sciences, Inc. $CAI - MarketBeat

Aug 27, 2026

Aug 26, 2026

Caris Life Sciences (NASDAQ:CAI) Trading Down 6.2% - What's Next? - marketbeat.com

Aug 26, 2026

Ähnlich wie CAI